Physician profile
Khalil Abu-Jubara
NPI 1467294645
$1,145.53
in general payments reported to CMS, 2019-2025
10 companies · $788 in 2025
The $788 reported for 2025 was more than what 84% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $358 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $203.71 | 2024 | Avitus Bone Harvester, Tapestry |
| Kerecis Limited | $195.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $135.77 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Tactile Systems Technology INC | $127.88 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $121.35 | 2025 | Krystexxa |
| Globus Medical, INC. | $115.01 | 2025 | Senza |
| Mimedx Group, INC. | $112.94 | 2025 | |
| Pinnacle, INC | $95.95 | 2024-2025 | |
| Organogenesis INC. | $23.93 | 2025 | Puraply Wound Matrix |
| Paragon 28, INC. | $13.63 | 2025 | Precision Mis Bunion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil Abu-Jubara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.